Eupraxia Pharmaceuticals is trading 6.67% up at $8.00 on September 4, 2026; no new company-specific announcement or reliable source explicitly explains the move.
- The Nasdaq listing transfer from OTC Pink to Nasdaq Global Market became effective September 3, but available coverage does not connect it causally to the increase.
- The broader healthcare sector has shown strength, while the wider market is trading lower.